RbAp46 inhibits estrogen-stimulated progression of neoplastigenic breast epithelial cells

Anticancer Research

Volumn 27, Issue 5 A, 2007, Pages 3205-3209

  Zhang, Teng Fei ^a,b   Yu, Shui Qing ^a,c   Wang, Zhao Yi ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c New York Presbyterian Morgan Stanley Children's Hospital   (United States)

Author keywords

catenin; Breast cancer; Estrogen signaling; RbAp46; Tumorigenesis

Indexed keywords

BETA CATENIN; CARRIER PROTEIN; ESTROGEN; HISTONE; PROTEIN RBAP46; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER GROWTH; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; STEADY STATE; WESTERN BLOTTING;

ANIMALS; BETA CATENIN; BREAST NEOPLASMS; CARRIER PROTEINS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; DISEASE PROGRESSION; DOWN-REGULATION; EPITHELIAL CELLS; ESTRADIOL; ESTRADIOL ANTAGONISTS; FEMALE; HUMANS; MICE; MICE, NUDE; NUCLEAR PROTEINS; PHOSPHORYLATION; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 35348959966     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Feigelson HS and Henderson BE: Estrogens and breast cancer. Carcinogenesis 17: 2279-2284, 1996.
2. Prall OWJ, Rogan EM and Sutherland RL: Estrogen regulation of cell cycle progression in breast cancer cells. J Steroid Biochem Molec Biol 65: 169-174, 1998.
3. Persico E, Scalona M, Cicatiello L, Sica V, Bresciani F and Weisz A: Activation of "immediate-early" genes by estrogen is not sufficient to achieve stimulation of DNA synthesis in rat uterus. Biochem Biophys Res Commun 171: 287-291, 1990.
4. Miller FR, Soule HD, Tait L, Pauley RJ, Wolman SR, Dawson PJ and Heppner GH: Xenograft model of progressive human proliferative breast disease. J Natl Cancer Inst 85: 1725-1732, 1993.
5. Dawaon PJ, Wolman SR, Tait L, Heppner GH and Miller FR: MCF10AT: A model for the evolution of cancer from proliferative breast disease. Am J Pathl 148: 313-319, 1996.
6. Shekhar MPV, Chen ML, Werdell J, Heppner GH, Miller FR and Christman JK: Transcriptional activation of functional endogenous estrogen receptor gene expression in MCF10AT cells: a model for early breast cancer. Int J Oncol 13: 907-915, 1998.
7. Shekhar MPV, Nangia-Makker P, Wolman SR, Tait L, Heppner GH and Visscher DW: Direct action of estrogen on sequence of progression of human preneoplastic breast disease. Am J Path 152: 1129-1132, 1998.
8. Qian YW, Wang YC, Hollingsworth RE Jr, Jones D, Ling N and Lee EY: A retinoblastoma-binding protein related to a negative regulator of Ras in yeast. Nature 364: 648-652, 1993.
9. Zhang Y, Iratni R, Erdjument-Bromage H, Tempst P and Reinberg D: Histone deacetylases and SAP18, a novel polypeptide, are components of a human Sin3 complex. Cell 89: 357-364, 1997.
10. Magnaghi-Jaulin L, Groisman R, Naguibneva I, Robin P, Lorain S, Le Villain JP, Troalen F, Trouche D and Harel-Bellan A: Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391: 601-605, 1998.
11. Guan LS, Rauchman M and Wang ZY: Induction of Rb associated protein (RbAp46) by Wilms' tumor suppressor WT1 mediates growth inhibition. J Biol Chem 273: 27047-27050, 1998.
12. Guan LS, Li GC, Chen GC, Liu LQ and Wang ZY: Rb associated protein (RbAp46) suppresses the transformed phenotypes of HEK 293 cells. Intl J Cancer 93: 333-338, 2001.
13. Li GC and Wang ZY: Rb Associated protein 46 (RbAp46) attenuates β-catenin/TCF signaling through up-regulation of GSK-3b expression. Anticancer Res 26: 4511-4518, 2006.
14. Yarden RI and Brody LC: BRCA1 interacts with components of the histone deacetylase complex. Proc Natl Acad Sci USA 96: 4983-4988, 1999.
15. Chen GC, Guan LS, Yu HJ, Li GC, Choi KH and Wang ZY: Rb-associated protein 46 (RbAp46) inhibits transcriptional transactivation mediated by BRCA1. Biochem. Biophys. Res. Commun 284: 507-514, 2001.
16. Zhang TF, Yu SQ, Guan LS and Wang ZY: Constitutive expression of Rb associated protein 46 (RbAp46) suppresses transformed phenotypes of breast cancer cells. Anticancer Res 23: 3735-3740, 2003.
17. Li GC and Wang ZY: Rb Associated protein 46 (RbAp46) attenuates β-catenin/TCF signaling through up-regulation of GSK-3b expression. Anticancer Res 26: 4511-4518, 2006.
18. Hülsken J and Behrens J: The Wnt signaling pathway. J Cell Sci 113: 3545-3548, 2000.
19. Chandar N, Saluja R, Lamar PC, Kolman K and Prozialeck WC: p53 and beta-catenin activity during estrogen treatment of osteoblasts. Cancer Cell International 5: 24-28, 2005.
20. Kouzmenko A P, Takeyama K, Ito S, Furutani T, Sawatsubashi S, Maki A, Suzuki E, Kawasaki Y, Akiyama T, Tabata T and Kato S: Wnt/β-catenin and estrogen signaling converge in vivo. J Bio Chem 279: 40255-40258, 2004.